American Century Companies’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3M | Buy |
432,731
+71,343
| +20% | +$2.36M | 0.01% | 1234 |
|
|
2025
Q1 | $14.5M | Buy |
361,388
+4,812
| +1% | +$193K | 0.01% | 1179 |
|
|
2024
Q4 | $16.8M | Buy |
356,576
+27,619
| +8% | +$1.3M | 0.01% | 1141 |
|
|
2024
Q3 | $17.4M | Sell |
328,957
-2,487
| -0.8% | -$131K | 0.01% | 1084 |
|
|
2024
Q2 | $18M | Sell |
331,444
-84,410
| -20% | -$4.57M | 0.01% | 1013 |
|
|
2024
Q1 | $29.2M | Sell |
415,854
-551,146
| -57% | -$38.6M | 0.02% | 777 |
|
|
2023
Q4 | $80.7M | Sell |
967,000
-1,258,762
| -57% | -$105M | 0.06% | 358 |
|
|
2023
Q3 | $65.6M | Sell |
2,225,762
-499,060
| -18% | -$14.7M | 0.05% | 376 |
|
|
2023
Q2 | $88.9M | Buy |
2,724,822
+46,124
| +2% | +$1.5M | 0.07% | 304 |
|
|
2023
Q1 | $94.2M | Buy |
2,678,698
+1,496,881
| +127% | +$52.7M | 0.07% | 287 |
|
|
2022
Q4 | $54.2M | Buy |
1,181,817
+718,472
| +155% | +$32.9M | 0.04% | 396 |
|
|
2022
Q3 | $22.4M | Buy |
463,345
+23,203
| +5% | +$1.12M | 0.02% | 634 |
|
|
2022
Q2 | $17.3M | Buy |
440,142
+29,989
| +7% | +$1.18M | 0.01% | 725 |
|
|
2022
Q1 | $15.1M | Sell |
410,153
-6,344
| -2% | -$234K | 0.01% | 776 |
|
|
2021
Q4 | $19M | Buy |
416,497
+67,504
| +19% | +$3.08M | 0.01% | 714 |
|
|
2021
Q3 | $12.5M | Buy |
+348,993
| New | +$12.5M | 0.01% | 785 |
|
|
2015
Q4 | – | Sell |
-16,541
| Closed | -$111K | – | 1307 |
|
|
2015
Q3 | $111K | Buy |
+16,541
| New | +$111K | ﹤0.01% | 1327 |
|
|
2014
Q4 | – | Sell |
-42,052
| Closed | -$148K | – | 1414 |
|
|
2014
Q3 | $148K | Buy |
+42,052
| New | +$148K | ﹤0.01% | 1389 |
|
|
2014
Q1 | – | Sell |
-100,840
| Closed | -$655K | – | 1456 |
|
|
2013
Q4 | $655K | Sell |
100,840
-94,570
| -48% | -$614K | ﹤0.01% | 1308 |
|
|
2013
Q3 | $1.48M | Buy |
+195,410
| New | +$1.48M | ﹤0.01% | 1156 |
|